Publications
Detailed Information
Molecular Testing of Lymphoproliferative Disorders: Current Status and Perspectives
Cited 7 time in
Web of Science
Cited 13 time in Scopus
- Authors
- Issue Date
- 2017-05
- Publisher
- 대한병리학회
- Citation
- Journal of Pathology and Translational Medicine, Vol.51 No.3, pp.224-241
- Abstract
- Molecular pathologic testing plays an important role for the diagnosis, prognostication and decision of treatment strategy in lymphoproliferative disease. Here, we briefly review the molecular tests currently used for lymphoproliferative disease and those which will be implicated in clinical practice in the near future. Specifically, this guideline addresses the clonality test for B-and T-cell proliferative lesions, molecular cytogenetic tests for malignant lymphoma, determination of cell-of-origin in diffuse large B-cell lymphoma, and molecular genetic alterations incorporated in the 2016 revision of the World Health Organization classification of lymphoid neoplasms. Finally, a new perspective on the next-generation sequencing for diagnostic, prognostic, and therapeutic purpose in malignant lymphoma will be summarized.
- ISSN
- 2383-7837
- Files in This Item:
- There are no files associated with this item.
- Appears in Collections:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.